Levofloxacin Unimed Pharma

Levofloxacin, the active ingredient in Levofloxacin Unimed Pharma, is a fluoroquinolone antibiotic presented as an ophthalmic preparation for ocular use. It treats bacterial conjunctivitis and keratitis in patients requiring topical eye therapy.

GNH USA supplies Levofloxacin Unimed Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin is a broad‑spectrum fluoroquinolone used to manage bacterial infections of the eye.

- Bacterial conjunctivitis: reduces bacterial load and resolves ocular surface infection. - Bacterial keratitis: eradicates corneal pathogens and promotes healing of the corneal epithelium. - Post‑operative ocular infection: prevents bacterial proliferation after eye surgery.

Levofloxacin ophthalmic solution may cause local and systemic adverse reactions.

Common Side Effects: - Eye irritation or burning sensation. - Redness of the conjunctiva. - Excessive tearing. - Foreign body sensation. - Transient blurred vision. - Mild headache.

Serious or Rare Side Effects: - Allergic reactions including anaphylaxis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Severe ocular inflammation or corneal ulceration. - Tendon rupture (systemic exposure). - Vision loss. - Systemic hypersensitivity with rash or fever.

Before prescribing Levofloxacin ophthalmic solution, consider the following precautions.

- Hypersensitivity: avoid use in patients with known fluoroquinolone allergy. - Corneal integrity: use with caution in eyes with epithelial defects or severe dry eye. - Systemic exposure: monitor patients with renal impairment for potential systemic accumulation. - Concomitant steroids: avoid unless necessary, as steroids may increase risk of corneal thinning. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at room temperature: keep in original container, protect from moisture and light.

Levofloxacin ophthalmic solution can interact with other systemic or ocular agents.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase total fluoroquinolone exposure. - QT‑prolonging drugs: combined effect may raise risk of cardiac arrhythmia. - Corticosteroid eye drops: may heighten risk of corneal thinning and delayed healing.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may reduce tear production, affecting drug distribution. - Non‑steroidal anti‑inflammatory eye drops: monitor for additive irritation. - Herbal supplements containing quinine: potential additive QT prolongation.